Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:TRHC

Tabula Rasa HealthCare - TRHC Stock Forecast, Price & News

$3.77
-0.07 (-1.82%)
(As of 11/25/2022 08:58 PM ET)
Add
Compare
Today's Range
$3.57
$3.88
50-Day Range
$3.19
$5.04
52-Week Range
$2.09
$16.82
Volume
33,300 shs
Average Volume
810,127 shs
Market Capitalization
$102.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.92

Tabula Rasa HealthCare MarketRank™ Forecast

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
136.5% Upside
$8.92 Price Target
Short Interest
Bearish
5.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.46mentions of Tabula Rasa HealthCare in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.90) to ($0.79) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

768th out of 1,044 stocks

Business Services, Not Elsewhere Classified Industry

79th out of 95 stocks

TRHC stock logo

About Tabula Rasa HealthCare (NASDAQ:TRHC) Stock

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

TRHC Stock News Headlines

Tabula Rasa HealthCare Reports Third Quarter 2022 Results
TRHC Adds Ron Mitchell to its Board of Directors
Tabula Rasa HealthCare Announces Leadership Transition
See More Headlines
Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

TRHC Company Calendar

Last Earnings
11/03/2022
Today
11/27/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRHC
Fax
N/A
Employees
1,602
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.92
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+136.5%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

Net Income
$-79,060,000.00
Pretax Margin
-32.43%

Debt

Sales & Book Value

Annual Sales
$331.26 million
Cash Flow
$0.24 per share
Book Value
($1.17) per share

Miscellaneous

Free Float
25,158,000
Market Cap
$102.26 million
Optionable
Optionable
Beta
1.66

Key Executives

  • Mr. Brian W. AdamsMr. Brian W. Adams (Age 40)
    Interim CEO, Pres & Sec.
    Comp: $515.63k
  • Mr. Michael  GreenhalghMr. Michael Greenhalgh (Age 60)
    Chief Operating Officer
    Comp: $507.79k
  • Mr. Thomas J. Cancro C.F.A. (Age 54)
    CPA, Chief Financial Officer
  • Ms. Andrea Carolan Speers M.S.Ms. Andrea Carolan Speers M.S. (Age 41)
    Corp. Controller & Chief Accounting Officer
  • Mr. Bob Sullivan M.S.
    Chief Technology Officer
  • Dr. Jacques Turgeon B.Pharm. (Age 62)
    Ph.D., Chief Scientific Officer & CEO of TRHC Precision Pharmacotherapy, R&D Institute
  • Mr. Phillip W. Heath MS (Age 56)
    Chief Admin. Officer
  • Mr. Frank Sparacino C.F.A.
    CPA, Sr. VP of Investor Relations & Corp. Devel.
  • Mr. Kevin J. Dill DMIN
    J.D., Gen. Counsel
  • Ms. Kathleen D Larkin M.B.A.
    Chief People Officer













TRHC Stock - Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View TRHC analyst ratings
or view top-rated stocks.

What is Tabula Rasa HealthCare's stock price forecast for 2023?

6 equities research analysts have issued twelve-month target prices for Tabula Rasa HealthCare's stock. Their TRHC share price forecasts range from $4.00 to $15.00. On average, they expect the company's stock price to reach $8.92 in the next twelve months. This suggests a possible upside of 136.5% from the stock's current price.
View analysts price targets for TRHC
or view top-rated stocks among Wall Street analysts.

How have TRHC shares performed in 2022?

Tabula Rasa HealthCare's stock was trading at $15.00 at the beginning of 2022. Since then, TRHC stock has decreased by 74.9% and is now trading at $3.77.
View the best growth stocks for 2022 here
.

When is Tabula Rasa HealthCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TRHC earnings forecast
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) released its quarterly earnings results on Thursday, November, 3rd. The company reported ($0.94) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.78. The company had revenue of $77.10 million for the quarter, compared to analysts' expectations of $73.68 million. Tabula Rasa HealthCare had a negative net margin of 46.03% and a negative trailing twelve-month return on equity of 472.90%.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $294.00 million-$297.00 million, compared to the consensus revenue estimate of $289.47 million.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.40%), Jacobs Levy Equity Management Inc. (2.31%), UBS Group AG (1.39%), Two Sigma Advisers LP (1.22%), Two Sigma Investments LP (1.16%) and Renaissance Technologies LLC (0.69%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Orsula V Knowlton, Orsula V Knowlton and Samira Beckwith.
View institutional ownership trends
.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $3.77.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $102.24 million and generates $331.26 million in revenue each year. The company earns $-79,060,000.00 in net income (profit) each year or ($5.81) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

The company employs 1,602 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.

This page (NASDAQ:TRHC) was last updated on 11/28/2022 by MarketBeat.com Staff